Inspire Medical Systems (INSP) Shows Improved Sleep Apnea Outcomes with Inspire V System

Core Insights - Inspire Medical Systems, Inc. (NYSE:INSP) is recognized as one of the top medical device stocks to invest in, particularly due to its recent clinical data showcasing the effectiveness of its Inspire V system for treating obstructive sleep apnea [1][3] Group 1: Clinical Data and Performance - On October 10, Inspire Medical Systems published clinical data from a restricted U.S. market release at ten medical centers and a clinical investigation in Singapore [1] - The Singapore study revealed a 20% reduction in surgical times compared to the previous Inspire IV system, with all procedures successfully completed for 44 patients [2] - The Inspire V system demonstrated superior performance in respiratory sensing, achieving an inspiratory phase overlap percentage of 87.1% compared to 79.4% for its predecessor [2]